| Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress S Bursać, MC Brdovčak, M Pfannkuchen, I Orsolić, L Golomb, Y Zhu, ... Proceedings of the National Academy of Sciences 109 (50), 20467-20472, 2012 | 248 | 2012 |
| Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis MS Lindström, D Jurada, S Bursac, I Orsolic, J Bartek, S Volarevic Oncogene 37 (18), 2351-2366, 2018 | 245 | 2018 |
| Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis S Bursac, MC Brdovcak, G Donati, S Volarevic Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (6), 817-830, 2014 | 176 | 2014 |
| Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer G Velimezi, M Liontos, K Vougas, T Roumeliotis, J Bartkova, M Sideridou, ... Nature cell biology 15 (8), 967-977, 2013 | 134 | 2013 |
| The p53 Tumor Suppressor Causes Congenital Malformations in Rpl24-Deficient Mice and Promotes Their Survival M Barkić, S Crnomarković, K Grabušić, I Bogetić, L Panić, S Tamarut, ... Molecular and cellular biology 29 (10), 2489-2504, 2009 | 112 | 2009 |
| Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. MO DR Bublik, S Bursać, M Sheffer, I Oršolić, T Shalit, O Tarcic, E Kotler ... Proceedings of the National Academy of Sciences 114 (4), 496-505, 2017 | 71 | 2017 |
| Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer S Bursać, Y Prodan, N Pullen, J Bartek, S Volarević Trends in Cancer, 2020 | 58 | 2020 |
| Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint I Oršolić, S Bursać, D Jurada, I Drmić Hofman, Z Dembić, J Bartek, ... Oncogene 39 (17), 3443-3457, 2020 | 43 | 2020 |
| RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis P Moudry, K Chroma, S Bursac, S Volarevic, J Bartek Cell Death & Differentiation 29 (3), 687-696, 2022 | 22 | 2022 |
| Physical and functional interaction of the TPL2 kinase with nucleophosmin DC Kanellis, S Bursac, PN Tsichlis, S Volarevic, AG Eliopoulos Oncogene 34 (19), 2516-2526, 2015 | 12 | 2015 |
| New insights into HEATR1 functions S Bursać, D Jurada, S Volarević Cell Cycle 17 (2), 143-144, 2018 | 6 | 2018 |
| ADAR1 p150 prevents HSV-1 from triggering PKR/eIF2α-mediated translational arrest and is required for efficient viral replication A Parchure, M Cesarec, V Ivanišević, M Čunko, S Bursać, R de Reuver, ... bioRxiv, 2024.07. 29.605561, 2024 | | 2024 |
| Ribosomal protein L5 and L11 play a major role in p53 activation upon ribosomal and genotoxic stresses B Cokarić, S Bursać, I Oršolić, D Jurada, S Volarević VI. HRVATSKI KONGRES HUMANE GENETIKE, 2015 | | 2015 |
| The role of ribosomal proteins in activation of tumor suppressor p53 S Bursać Medicinski fakultet, Sveučilište u Rijeci, 2013 | | 2013 |
| Uloga ribosomskih proteina u aktivaciji supresora tumora p53 S Bursać University of Rijeka. Faculty of Medicine, 2013 | | 2013 |
| RIBOSOMAL PROTEINS L5 AND L11 PARTICIPATE IN ACTIVATION OF THE P53 TUMOR SUPPRESSOR IN RESPONSE TO MANY DIFFERENT STRESSES K Grabušić, R Mihovilić, S Bursać, S Volarević 10th Congress of the Croatian society of Biochemistry and Molecular Biology …, 2010 | | 2010 |
| The Role of Ribosomal Proteins L5 and L11 in Tumor Suppression I Oršolić, S Bursać, S Volarević Functional Genomics Workshop, 0 | | |
